US HB9011 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on September 28 2022 - 25% progression, died in committee
Action: 2022-09-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 28 2022 - 25% progression, died in committee
Action: 2022-09-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information, and for other purposes.
Title
Updated Drug Labeling for Patient Safety Act
Sponsors
| Rep. Donald McEachin [D-VA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-09-29 | House | Referred to the Subcommittee on Health. |
| 2022-09-28 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-09-28 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/9011/all-info |
| Text | https://www.congress.gov/117/bills/hr9011/BILLS-117hr9011ih.pdf |
